{"id":225017,"date":"2021-07-25T06:50:24","date_gmt":"2021-07-24T22:50:24","guid":{"rendered":"http:\/\/www.cailiaoniu.com\/?p=225017"},"modified":"2021-07-24T18:58:28","modified_gmt":"2021-07-24T10:58:28","slug":"%e5%a4%8d%e6%97%a6%e5%a4%a7%e5%ad%a6advanced-science%e6%8a%a5%e9%81%93%ef%bc%9a%e4%b8%80%e7%a7%8d%e8%82%bf%e7%98%a4%e9%9d%b6%e5%90%91%e7%ba%b3%e7%b1%b3%e5%b9%b3%e5%8f%b0%e7%94%a8%e4%ba%8e%e7%bb%93","status":"publish","type":"post","link":"http:\/\/www.cailiaoniu.com\/?p=225017","title":{"rendered":"\u590d\u65e6\u5927\u5b66Advanced Science\uff1a\u4e00\u79cd\u80bf\u7624\u9776\u5411\u7eb3\u7c73\u5e73\u53f0\u7528\u4e8e\u7ed3\u76f4\u80a0\u764c\u8179\u819c\u8f6c\u79fb\u7684\u8bca\u7597"},"content":{"rendered":"

\u3010\u80cc\u666f\u4ecb\u7ecd\u3011<\/strong><\/p>\n

\u7ed3\u76f4\u80a0\u764c\u6781\u6613\u51fa\u73b0\u8179\u819c\u8f6c\u79fb\uff08CRC-PM\uff09\uff0c5\u5e74\u751f\u5b58\u7387\uff1c10%\u3002\u7531\u4e8e\u6563\u5728\u591a\u53d1\uff0c\u4e34\u5e8a\u4e0aCRC-PM\u7684\u793a\u8e2a\u4e0e\u6cbb\u7597\u5747\u6781\u5176\u56f0\u96be\u3002\u5176\u57fa\u7840\u65b9\u6848\u4e3a\u8179\u8154\u70ed\u704c\u6ce8\u5316\u7597\uff0c\u8179\u8154\u7f6e\u7ba1\u5e76\u704c\u6ce8\u70ed\u5316\u7597\u6db2\uff0c\u901a\u8fc7\u9ad8\u6e29\u548c\u5316\u7597\u6740\u4f24\u80bf\u7624\uff0c\u867d\u4e3a\u57fa\u7840\u6cbb\u7597\u7b56\u7565\uff0c\u8179\u8154\u70ed\u704c\u6ce8\u4e0eCRC-PM\u75c5\u7406\u7279\u5f81\u548c\u6cbb\u7597\u9700\u6c42\u5374\u5e76\u975e\u5b8c\u5168\u5951\u5408\uff0c\u526f\u4f5c\u7528\u663e\u8457\u3002\u4e34\u5e8a\u5e94\u752830\u5e74\u6765\uff0c\u6cbb\u7597\u6a21\u5f0f\u51e0\u65e0\u5b9e\u8d28\u8fdb\u5c55\u3002<\/p>\n

\u5f53\u524d\u4e3b\u8981\u5b58\u5728\u4e24\u5927\u95ee\u9898\u662f\u7f3a\u4e4f\u9488\u5bf9\u80bf\u7624\u7684\u6cbb\u7597\u7cbe\u51c6\u6027\uff1a\u8179\u819c\u8868\u9762\u79ef\u5927\uff0cCRC-PM\u6563\u5728\u591a\u53d1\uff0c\u5f02\u8d28\u6027\u5f3a\uff1b\u800c\u8179\u8154\u704c\u6ce8\u5c5e\u4e8e\u5178\u578b\u7684\u201c\u5927\u6c34\u6f2b\u704c\u201d\uff0c\u704c\u6ce8\u7684\u77ed\u65f6\u95f4\u5185\u836f\u7269\u65e0\u6cd5\u9009\u62e9\u6027\u5730\u4ec5\u5bcc\u96c6\u4e8e\u80bf\u7624\u7ec4\u7ec7\uff0c\u63a5\u89e6\u66f4\u591a\u7684\u662f\u5065\u5eb7\u7ec4\u7ec7\uff1b\u8179\u8154\u5185\u5927\u8303\u56f4\u52a0\u70ed\u4e5f\u4f1a\u635f\u4f24\u6b63\u5e38\u7ec4\u7ec7\u300295%\u7684\u63a5\u53d7\u8179\u8154\u70ed\u704c\u6ce8\u7684\u75c5\u4eba\u5747\u4f1a\u51fa\u73b0\u526f\u4f5c\u7528\uff0c\u5982\u809d\/\u80be\/\u80c3\u80a0\u9053\u6bd2\u6027\u3001\u9aa8\u9ad3\u6291\u5236\u7b49\uff0c\u4ec57%\u7684\u75c5\u4eba\u53ef\u63a5\u53d7\u518d\u6b21\u7684\u8179\u8154\u70ed\u704c\u6ce8\u6cbb\u7597\u3002\u56e0\u6b64\u836f\u7269\u5728\u80bf\u7624\u75c5\u7076\u9ad8\u6548\u6d53\u96c6\u662f\u89e3\u51b3\u5f53\u524dCMC-PM\u6cbb\u7597\u56f0\u5883\u7684\u524d\u63d0\u3002\u56e0\u6b64\u9700\u6784\u5efa\u53ef\u9776\u5411CRC-PM\u75c5\u7076\u7684\u836f\u7269\u9012\u91ca\u7cfb\u7edf\uff0c\u4ee5\u589e\u52a0\u836f\u7269\u5728\u80bf\u7624\u90e8\u4f4d\u7684\u84c4\u79ef\uff0c\u63d0\u9ad8\u6cbb\u7597\u7cbe\u51c6\u6027\u3002<\/p>\n

\u6b64\u5916\uff0cCMC-PM\u7684\u75c5\u7076\u793a\u8e2a\u5b58\u5728\u6781\u5927\u56f0\u96be\u3002\u5f53\u524d\u4e34\u5e8a\u8bca\u65ad\u65b9\u6cd5\u5305\u62ec\uff1a\u6d3b\u68c0\u75c5\u7406\uff08\u7ec6\u80de\u5b66\u3001\u7ec4\u7ec7\u75c5\u7406\u5b66\uff09\uff1b\u80bf\u7624\u6297\u539f\uff08CEA\u3001CA199\u3001CA125\uff09\uff1b\u5f71\u50cf\u5b66\uff08CT\u3001MRI\u3001PET-CT\u3001\u8d85\u58f0\uff09\u7b49\u3002\u5404\u6709\u6240\u957f\uff0c\u4e5f\u5404\u6709\u6240\u9650\uff1a\u75c5\u7406\u6d3b\u68c0\u6709\u6ede\u540e\u6027\uff0c\u4e00\u822c\u610f\u5473\u7740\u5df2\u6f14\u8fdb\u81f3\u7ec8\u672b\u671f\uff1b\u80bf\u7624\u6297\u539f\u7075\u654f\u5ea6\u548c\u68c0\u51fa\u5ea6\u6709\u9650\uff1bMRI\u5b58\u5728\u4f2a\u5f71\u3001\u8102\u80aa\u3001\u7ed3\u8282\u5e72\u6270\u7b49\u3002\u589e\u5f3aCT\uff0c\u4f5c\u4e3a\u5f53\u524d\u4e34\u5e8a\u91d1\u6807\u51c6\uff0c\u603b\u786e\u8bca\u7387\u4ec5\u7ea640%\uff0c\u53ea\u80fd\u5206\u8fa8\u51fa5 mm\u53ca\u4ee5\u4e0a\u8f6c\u79fb\u7076\uff0c\u5bf9<5 mm\u7684\u8f6c\u79fb\u7076\u53ea\u670911\uff05\u7684\u654f\u611f\u6027\u3002\u6709\u524d\u77bb\u6027\u7814\u7a76\u62a5\u9053\uff0c\u8367\u5149\u8f85\u52a9\u8179\u8154\u955c\u6280\u672f\u53ef\u53d1\u73b01 mm\u5de6\u53f3\u65e9\u671f\u8f6c\u79fb\u7076\uff0c\u4f46\u4ecd\u5b58\u5728\u5065\u5eb7\u7ec4\u7ec7\u548c\u80bf\u7624\u7ec4\u7ec7\u96be\u4ee5\u5206\u8fa8\u7684\u95ee\u9898\u3002\u56e0\u6b64\uff0c\u4e9f\u5f85\u53d1\u5c55\u4e00\u79cd\u201cOff-to-On\u201d\u578b\u8fd1\u7ea2\u5916\u8367\u5149\u63a2\u9488\u4f53\u7cfb\uff0c\u7528\u4e8e\u5728\u80bf\u7624\u7279\u5f02\u5fae\u73af\u5883\u4e0b\u6fc0\u6d3b\uff0c\u6765\u533a\u5206\u5065\u5eb7\u548c\u80bf\u7624\u7ec4\u7ec7\u3002<\/p>\n

\u3010\u6210\u679c\u7b80\u4ecb\u3011<\/strong><\/p>\n

\u57fa\u4e8e\u6b64\uff0c\u590d\u65e6\u5927\u5b66\u836f\u5b66\u9662\u7684\u5b59\u6d9b\u526f\u6559\u6388\uff08\u7b2c\u4e00\u4f5c\u8005\uff09\u3001\u848b\u6668\u6559\u6388\uff08\u901a\u8baf\u4f5c\u8005\uff09<\/strong>\u9075\u5faaCRC-PM\u57fa\u672c\u6cbb\u7597\u539f\u5219\uff0c\u4ece\u80bf\u7624\u56fa\u6709\u7279\u5f81\u51fa\u53d1\uff0c\u7efc\u5408\u836f\u5242\u5b66\u3001\u6709\u673a\u5316\u5b66\u3001\u6750\u6599\u5b66\u3001\u5f71\u50cf\u5b66\u7b49\u624b\u6bb5\uff0c\u4ee5\u5206\u5b50\u8bbe\u8ba1\u4e3a\u57fa\u7840\u5de5\u5177\uff0c\u4ee5\u6c27\u5316\u578b\u6297\u574f\u8840\u9178\u4e3a\u5c0f\u5206\u5b50\u9776\u5411\u529f\u80fd\u57fa\u56e2\uff0c\u6784\u5efa\u4e86CRC-PM\u80bf\u7624\u9776\u5411\u7684\u56fa\u8f7d\u5965\u6c99\u5229\u94c2\u7684\u805a\u5408\u7269\u80f6\u675f\uff0c\u5b9e\u73b0GLUT1\u4ecb\u5bfc\u7684\u836f\u7269\u7684\u80bf\u7624\u5bcc\u96c6\uff0c\u5fae\u73af\u5883\u523a\u6fc0\u4e0b\u5965\u6c99\u5229\u94c2\u53ca\u5149\u8bca\u7597\u5242\u7684\u91ca\u653e\u548c\u57fa\u4e8e\u6b64\u7684\u539f\u4f4d\u5149\u70ed\u6548\u5e94\uff0c\u5b9e\u73b0\u4e86\u80bf\u7624\u75c5\u7076\u793a\u8e2a\uff0c\u63d0\u9ad8\u4e86\u6cbb\u7597\u7cbe\u51c6\u6027\uff0c\u6700\u7ec8\u5b9e\u73b0\u5316\u7597\u589e\u654f\u3001\u836f\u7269\u589e\u6e17\u53ca\u5b9a\u70b9\u70ed\u7597\u3002\u8fd1\u65e5\uff0c\u76f8\u5173\u6210\u679c\u4ee5\u300a\u4e00\u79cd\u591a\u529f\u80fd\u8bca\u7597\u5e73\u53f0\u7528\u4e8e\u7ed3\u76f4\u80a0\u764c\u8179\u819c\u8f6c\u79fb\u7684\u75c5\u7076\u8ffd\u8e2a\u548c\u5149\u70ed\u4fc3\u8fdb\u5316\u7597\u589e\u654f\u300b\uff08A Versatile Theranostic Platform for Colorectal Cancer Peritoneal Metastases: Real-Time Tumor-Tracking and Photothermal-Enhanced Chemotherapy\uff09\u4e3a\u9898\uff0c\u5728\u7ebf\u53d1\u8868\u4e8e\u300a\u5148\u8fdb\u79d1\u5b66\u300b\uff08Advanced Science\uff09\u4e0a\u3002<\/p>\n

\u3010\u56fe\u6587\u89e3\u8bfb\u3011<\/strong><\/p>\n

\u56fe\u4e00\u3001<\/strong>\u4e00\u79cd\u80bf\u7624\u9776\u5411\u7eb3\u7c73\u5e73\u53f0\u7528\u4e8e\u7ed3\u76f4\u80a0\u764c\u8179\u819c\u8f6c\u79fb\u7684\u8bca\u7597\u793a\u610f\u56fe<\/strong><\/p>\n

\"\"<\/p>\n

\u56fe\u4e8c\u3001\u672c\u8bfe\u9898\u8bbe\u8ba1\u7684\u63a2\u9488\u6982\u5ff5\u9a8c\u8bc1<\/strong><\/p>\n

\"\"<\/p>\n

A\uff09S-DYE\u4e0eGSH\u53cd\u5e94\u751f\u6210DYE\u8fc7\u7a0b\u7684\u5316\u5b66\u7ed3\u6784\u53d8\u5316\uff1bB\uff09DYE\u7684S1\u6001\u7684\u524d\u7ebf\u5206\u5b50\u8f68\u9053\u4ee5\u53ca\u7535\u5b50\u4e91\u5206\u5e03\uff1bC\uff09S-DYE\u7684S1\u6001\u7684\u524d\u7ebf\u5206\u5b50\u8f68\u9053\u4ee5\u53ca\u7535\u5b50\u4e91\u5206\u5e03\uff1bD\uff09\u60f0\u6027\u7684C-DYE\u65e0\u6cd5\u4e0eGSH\u53cd\u5e94\u751f\u6210DYE\uff1bE\uff09DYE\u53caS-DYE\u5728\u542b\u6c34\u6eb6\u6db2\u4e2d\u7684\u5438\u6536\u5149\u8c31\uff1b F\uff09S-DYE\u5728GSH\u5b58\u5728\u4e0b\u8367\u5149\u589e\u5f3a\u7ed3\u679c\uff1bG\uff09C-DYE\u5728GSH\u5b58\u5728\u4e0b\u8367\u5149\u57fa\u672c\u4e0d\u53d8\u7ed3\u679c\uff1bH\uff09\u5728GSH\u5b58\u5728\u4e0b\u7684off-to-on\u52a8\u529b\u5b66\u7814\u7a76\uff1bI~J\uff09\u9176\u6807\u4eea\u68c0\u6d4bS-DYE\u4e0eHCT-116\u7ec6\u80de\u5b75\u80b2\u540e\u4e0d\u540c\u65f6\u95f4\u70b9\u7684\u8367\u5149\u5f3a\u5ea6\u53ca\u534a\u5b9a\u91cf\u7ed3\u679c\u3002<\/p>\n

\u56fe\u4e09\u3001\u80f6\u675f\u7684\u8868\u5f81\u53ca\u836f\u7269\u91ca\u653e\u52a8\u529b\u5b66\u7814\u7a76<\/strong><\/p>\n

\"\"<\/p>\n

\u80f6\u675f\u7684\u7ec4\u5206\u6784\u6210\u53ca\u5236\u5907\u8fc7\u7a0b\uff1b B\uff09\u80f6\u675f\u6784\u5efa\u6750\u6599CMC\u503c\u8868\u5f81\uff1bC\uff09\u7a7a\u80f6\u675f\u3001\u8f7d\u63a2\u9488\u80f6\u675f\u57284\u4e2d\u3001\u8f7d\u63a2\u9488\u80f6\u675f\u5728\u8840\u6e05\u4e2d\u7684\u03b6\u7535\u4f4d\uff1b D) \u57284\u2103\u4e0b\u653e\u7f6e\u4e00\u6bb5\u65f6\u95f4\u540e\uff0c\u8f7d\u836f\u80f6\u675f\u5728PBS\u6216\u8840\u6e05\u4e2d\u7684\u5927\u5c0f\u53d8\u5316\uff1bE\uff09\u8f7d\u836f\u80f6\u675fTEM\u8868\u5f81\u7ed3\u679c\uff1bF\uff09\u8f7d\u836f\u80f6\u675f\u5143\u7d20\u5206\u5e03\u7ed3\u679c\uff1bG\uff09GPC\u8868\u5f81\u7684Vc\u5b58\u5728\u4e0b\u5408\u6210\u7684\u805a\u5408\u7269\u6750\u6599\u5206\u5b50\u91cf\u53d8\u5316\u622a\u56fe\uff1bH\uff09Vc\u5b58\u5728\u4e0b\u80f6\u675f\u7c92\u5f84\u53d8\u5316\u7ed3\u679c\uff1bI\uff09\u5965\u6c99\u5229\u94c2\u91ca\u653e\u52a8\u529b\u5b66<\/p>\n

\u56fe\u56db\u3001\u7ec6\u80de\u6c34\u5e73\u8bc4\u4ef7<\/strong><\/p>\n

\"\"<\/p>\n

\u4e0d\u540c\u9776\u5411\u529f\u80fd\u57fa\u56e2\u63ba\u6742\u6bd4\u5bf9\u9776\u5411\u6548\u679c\u7684\u5f71\u54cd\uff1bB\uff09\u91c7\u7528\u4e0d\u540c\u7684\u6291\u5236\u6761\u4ef6\u5305\u62ec\u6e25\u66fc\u9752\u9709\u7d20\u3001\u6c2f\u4e19\u55ea\u3001\u83f2\u5f8b\u5bbe\u83cc\u7d20\u3001\u8fc7\u91cfD-\u8461\u8404\u7cd6\u548c4 \u2103\u5904\u7406\uff0c\u901a\u8fc7\u6d41\u5f0f\u786e\u5b9a\u7ec6\u80de\u6444\u53d6\u9014\u5f84;C\uff09\u4e0d\u540c\u65f6\u95f4\u5185off-to-on\u8fc7\u7a0b\u7684\u7814\u7a76\uff1bD\uff09\u4e0d\u540c\u5b75\u80b2\u65f6\u95f4DPPtP\/SD\u7684\u7ec6\u80de\u6444\u53d6\u5171\u805a\u7126\u6210\u50cf(\u6bd4\u5c3a\u663e\u793a5 \u03bcm)\u548c\u76f8\u5e94\u7684\u534a\u5b9a\u91cf\u7ed3\u679c\uff1bE)\u672c\u8bfe\u9898\u6d89\u53ca\u5230\u7684SO2<\/sub>\u63a2\u9488\u7684\u5386\uff1bF\uff09\u672c\u5e73\u53f0SO2<\/sub>\u91ca\u653e\u52a8\u529b\u5b66\uff1bG)\u5728\u7ec6\u80de\u6c34\u5e73\uff0c\u8367\u5149\u5f3a\u5ea6\u7684DYE\u6d53\u5ea6\u4f9d\u8d56\u6027\uff1bH\uff09\u5728\u7ec6\u80de\u6c34\u5e73\uff0cSO2<\/sub>\u91ca\u653e\u7684DYE\u6d53\u5ea6\u4f9d\u8d56\u6027\uff1bI\uff09\u4e0d\u540c\u6d53\u5ea6\u4e0bROS\u6c34\u5e73\u53d8\u5316\u3002<\/p>\n

\u56fe\u4e94\u3001\u4f53\u5185\u9776\u5411\u6027\u8bc4\u4ef7<\/strong><\/p>\n

\"\"<\/p>\n

\u56fe\u516d\u3001<\/strong>\u6297\u80bf\u7624\u836f\u6548\u7ed3\u679c\u3002<\/p>\n

\"\"<\/p>\n

\u572837 o<\/sup>C \u4e0b\uff0cHCT-116\u7ec6\u80de\u7ecf\u4e0d\u540c\u5236\u5242\u7ec4\u5904\u740624 h\u540e\uff0c\u5229\u7528CCK-8\u65b9\u6cd5\u68c0\u6d4b\u5f97\u5230\u7684\u7ec6\u80de\u751f\u5b58\u66f2\u7ebf\uff1bA\uff09\u572843 o<\/sup>C \u4e0b\uff0cHCT-116\u7ec6\u80de\u7ecf\u4e0d\u540c\u5236\u5242\u7ec4\u5904\u740624 h\u540e\uff0c\u5229\u7528CCK-8\u65b9\u6cd5\u68c0\u6d4b\u5f97\u5230\u7684\u7ec6\u80de\u751f\u5b58\u66f2\u7ebf\uff1b\u5728\u8377\u7ed3\u76f4\u80a0\u764c\u8179\u819c\u8f6c\u79fb\u539f\u4f4d\u7624\u6a21\u578b\u9f20\u4e0a\uff0c\u7ecf\u4e0d\u540c\u5236\u5242\u7ec4\u5904\u7406\u540e\u7684C\uff09\u5c0f\u9f20\u4f53\u91cd\u53d8\u5316\u66f2\u7ebf\uff1bD\uff09\u5c0f\u9f20\u751f\u5b58\u66f2\u7ebf\uff08n=8\uff09\uff1bE\uff09\u5229\u7528\u751f\u7269\u53d1\u5149\u8868\u5f81\u5c0f\u9f20\u80bf\u7624\u6f14\u8fdb\u60c5\u51b5\uff1b\u751f\u7269\u53d1\u5149\u534a\u5b9a\u91cf\u7684F\uff09\u6c47\u603b\u6027\u548cG\uff09\u72ec\u7acb\u7edf\u8ba1\u7ed3\u679c\uff08n=6\uff09\uff1b\u5728\u8377\u7ed3\u76f4\u80a0\u764c\u8179\u819c\u8f6c\u79fb\u539f\u4f4d\u7624\u6a21\u578b\u9f20\u4e0a\uff0c\u7ecf\u4e0d\u540c\u5236\u5242\u7ec4\u5904\u7406\u540e\u7684H\uff09\u8f6c\u79fb\u7076\u6570\u76ee\uff1bI\uff09\u8179\u6c34\u4f53\u79ef\uff1bJ\uff09\u5265\u79bb\u80bf\u7624\u603b\u91cd\u91cf\uff1bK\uff09\u8179\u6c34\u4e2d\u7ea2\u7ec6\u80de\u6570\u76ee\uff08n=6\uff09\uff1bL\uff09\u5229\u7528TUNEL\u539f\u4f4d\u68c0\u6d4b\u6cbb\u7597\u540e\u80bf\u7624\u7ec4\u7ec7\u4e2d\u7ec6\u80de\u51cb\u4ea1\u60c5\u51b5\uff08\u6bd4\u4f8b\u5c3a\u4e3a100 \u03bcm\uff09\u3002<\/p>\n

\u56fe\u4e03\u3001<\/strong>\u751f\u7269\u5b89\u5168\u6027\u8bc4\u4ef7\u3002<\/p>\n

\"\"<\/p>\n

A\uff09\u572837 o<\/sup>C \u4e0b\uff0c\u4eba\u80be\u4e0a\u76aeHEK-293\u7ec6\u80de\u5229\u7528\u4e0d\u540c\u5236\u5242\u7ec4\u5904\u740624 h\u540e\uff0c\u5229\u7528CCK-8\u65b9\u6cd5\u68c0\u6d4b\u5f97\u5230\u7684\u7ec6\u80de\u751f\u5b58\u66f2\u7ebf\uff1bB\uff09\u5728\u8377\u7ed3\u76f4\u80a0\u764c\u8179\u819c\u8f6c\u79fb\u539f\u4f4d\u7624\u6a21\u578b\u9f20\u4e0a\uff0c\u7ecf\u4e0d\u540c\u5236\u5242\u7ec4\u5904\u7406\u540e\u7684\u8179\u6c34\u4e2d\u7ea2\u7ec6\u80de\u6570\u76ee\uff08n=6\uff09\uff1bC\uff09\u5728\u8377\u7ed3\u76f4\u80a0\u764c\u8179\u819c\u8f6c\u79fb\u539f\u4f4d\u7624\u6a21\u578b\u9f20\u4e0a\uff0c\u7ecf\u4e0d\u540c\u5236\u5242\u7ec4\u5904\u7406\u540e\u7684\u5fc3\u809d\u813e\u80ba\u80be\u7684\u514d\u75ab\u7ec4\u5316\u5206\u6790\uff08\u6bd4\u4f8b\u5c3a\u4e3a50 \u03bcm\uff09\uff1b\u5728\u8377\u7ed3\u76f4\u80a0\u764c\u8179\u819c\u8f6c\u79fb\u539f\u4f4d\u7624\u6a21\u578b\u9f20\u4e0a\uff0c\u7ecf\u4e0d\u540c\u5236\u5242\u7ec4\u5904\u7406\u540e\u7684D\uff09\u767d\u86cb\u767d\uff1bE\uff09\u8f6c\u6c28\u9176\uff1bF\uff09\u5c3f\u7d20\uff1bG\uff09\u8c37\u8349\u8f6c\u6c28\u9176\uff1bH\uff09\u8840\u6e05\u78b1\u6027\u78f7\u9178\u9176\uff1bI\uff09\u808c\u9150\u6c34\u5e73\uff08n=3\uff09\u3002<\/p>\n

\u3010\u603b\u7ed3\u3011<\/strong><\/p>\n

\u7efc\u4e0a\u6240\u8ff0\uff0c\u4e0d\u540c\u4e8e\u4e0e\u4f20\u7edf\u7684\u8bca\u7597\u6a21\u5f0f\uff0c\u5728\u672c\u6587\u4e2d\u4f5c\u8005\u63d0\u51fa\u4e86\u4e00\u79cd\u6d89\u53ca\u4e00\u79cd\u5229\u7528\u539f\u4f4d\u5149\u70ed\u6280\u672f\u4fc3\u8fdb\u80bf\u7624\u7ec6\u80de\u51cb\u4ea1\u7684\u7b56\u7565\u3002\u5229\u7528\u4e00\u79cd\u8d1f\u8f7d\u5965\u6c99\u5229\u94c2\u548c\u5149\u70ed\u5206\u5b50\u7684\u9776\u5411\u80f6\u675f\uff0c\u5b9e\u73b0\u5411\u80bf\u7624\u7684\u7279\u5f02\u6027\u9012\u9001\u548c\u84c4\u79ef\u3002\u5728\u8fd1\u7ea2\u5916\u5149\u7167\u4e0b\uff0c\u5149\u70ed\u5206\u5b50\u539f\u4f4d\u4ea7\u751f\u70ed\u91cf\uff0c\u589e\u5f3a\u5965\u6c99\u5229\u94c2\u5316\u7597\u6548\u679c\uff0c\u540c\u65f6\u964d\u4f4e\u526f\u4f5c\u7528\u3002\u672c\u8bbe\u8ba1\u5229\u7528\u539f\u4f4d\u5149\u70ed\u6280\u672f\u4fc3\u8fdb\u80bf\u7624\u7ec6\u80de\u51cb\u4ea1\u7684\u7b56\u7565\uff0c\u6709\u671b\u4e3a\u9ad8\u6548CRC-PM\u80bf\u7624\u8bca\u7597\u63d0\u4f9b\u65b0\u65b9\u6cd5\u3002<\/p>\n

\u590d\u65e6\u5927\u5b66\u836f\u5b66\u9662\u836f\u5242\u5b66\u7cfb\u5b59\u6d9b\u526f\u6559\u6388\u548c\u848b\u6668\u6559\u6388\uff0c\u5206\u522b\u4e3a\u672c\u9879\u5de5\u4f5c\u7684\u7b2c\u4e00\u4f5c\u8005\u548c\u901a\u8baf\u4f5c\u8005\u3002\u672c\u7814\u7a76\u83b7\u56fd\u5bb6\u81ea\u7136\u79d1\u5b66\u57fa\u91d1\u91cd\u5927\u7814\u7a76\u8ba1\u5212\u57f9\u80b2\u9879\u76ee\u53ca\u91cd\u70b9\u9879\u76ee\u7684\u8d44\u52a9\u3002<\/p>\n

\u8bba\u6587\u94fe\u63a5\uff1ahttps:\/\/doi.org\/10.1002\/advs.202102256<\/p>\n

\u3010\u4f5c\u8005\u7b80\u4ecb\u3011<\/strong><\/p>\n

\u672c\u6587\u4f5c\u8005\u4e3a\u590d\u65e6\u5927\u5b66\u836f\u5b66\u9662\u848b\u6668\u6559\u6388\u56e2\u961f<\/strong>\uff1a<\/p>\n

\u848b\u6668\u6559\u6388\uff1a<\/strong>\u56fd\u5bb6\u6770\u9752\uff0c\u76ee\u524d\u62c5\u4efb\u590d\u65e6\u5927\u5b66\u836f\u5b66\u9662\u836f\u5242\u5b66\u7cfb\uff08\u56fd\u5bb6\u91cd\u70b9\u5b66\u79d1\uff09\u4e3b\u4efb\u3001\u667a\u80fd\u5316\u9012\u836f\u6559\u80b2\u90e8\u91cd\u70b9\u5b9e\u9a8c\u5ba4\u4e3b\u4efb\u3002\u7814\u7a76\u65b9\u5411\u4e3b\u8981\u96c6\u4e2d\u5728\u8111\u9776\u5411\u3001\u80bf\u7624\u9776\u5411\u7b49\u836f\u7269\u9012\u9001\u7cfb\u7edf\u7684\u8bbe\u8ba1\u3001\u6784\u5efa\u548c\u8bc4\u4ef7\u7684\u57fa\u7840\u5e94\u7528\u7814\u7a76\u3002<\/p>\n

\u5b59\u6d9b\u526f\u6559\u6388<\/strong>\uff1a\u590d\u65e6\u5927\u5b66\u5f15\u8fdb\u4eba\u624d\uff0c\u590d\u65e62025\u5353\u5b66\u8ba1\u5212\u83b7\u5f97\u8005\uff0c\u4e0a\u6d77\u79d1\u59d4\u5e02\u626c\u5e06\u8ba1\u5212\u4eba\u624d\u3001\u4e0a\u6d77\u4eba\u793e\u5c40\u4eba\u624d\u53d1\u5c55\u8d44\u91d1\u3002\u7814\u7a76\u65b9\u5411\u4e3a\u5229\u7528\u5206\u5b50\u8bbe\u8ba1\u6784\u5efa\u529f\u80fd\u578b\u836f\u7269\u9012\u9001\u7cfb\u7edf\uff0c\u91c7\u7528\u523a\u6fc0\u654f\u611f\u578b\u52a8\u6001\u952e\uff0c\u5bf9\u8bdd\u4e8e\u75be\u75c5\u5fae\u73af\u5883\uff0c\u5b9e\u73b0\u836f\u7269\u9ad8\u6548\u8d1f\u8f7d\u4e0e\u667a\u80fd\u91ca\u653e\u3002<\/p>\n

\u56e2\u961f\u4e3b\u9875\uff1ahttp:\/\/smartdds.fudan.edu.cn\/jiangchen\/Index.aspx<\/p>\n

\u3010\u8fd1\u5e74\u6765\u53d1\u8868\u8bba\u6587\u5217\u8868\u3011<\/strong><\/p>\n

2010\u5e74\u6765, \u5728\u56fd\u9645\u91cd\u8981\u5b66\u672f\u671f\u520a\u4e0a\u53d1\u8868\u591a\u7bc7\u9ad8\u8d28\u91cfSCI \u8bba\u6587, \u5176\u4e2dIF>10 \u7684\u901a\u8baf\u4f5c\u8005\u8bba\u658739\u7bc7, IF>8 \u7684\u8bba\u6587>60%. \u5305\u62ec\u4e0b\u5217\u8457\u540d\u56fd\u9645\u520a\u7269Advanced Materials, Advanced Functional Materials, Advanced Science, ACS Nano, Nano Letters, JACS, Biomaterials, Small\u548cJournal of Controlled Release<\/em>\u7b49, \u4ee3\u8868\u6027\u8bba\u6587\u5982\u4e0b:<\/p>\n

    \n
  1. Li C, Sun T, Jiang C*. Recent advances in nanomedicines for the treatment of ischemic stroke [J]. Acta Pharmaceutica Sinica B, 2020. https:\/\/doi.org\/10.1016\/j.apsb.2020.11.019<\/a><\/li>\n
  2. Liu, PX., Zhang, TY., Chen, QJ., Li, C., Chu, YC., Guo, Q., Zhang, YJ., Zhou, WX., Chen, HY., Zhou, Z., Wang, Y., Zhao, ZH., Luo, YF., Li, XW., Song, HL., Su, BY., Li, CF., Sun, T., Jiang, C.*, Biomimetic Dendrimer\u2013Peptide Conjugates for Early Multi\u2010Target Therapy of Alzheimer’s Disease by Inflammatory Microenvironment Modulation. Adv. Mater.<\/em> 2021, 2100746. https:\/\/doi.org\/10.1002\/adma.202100746<\/a><\/li>\n
  3. Chen, QJ., Sun, T. & Jiang, C*. Recent Advancements in Nanomedicine for \u2018Cold\u2019 Tumor Immunotherapy. Nano-Micro Lett.<\/em> 13, <\/strong>92 (2021). https:\/\/doi.org\/10.1007\/s40820-021-00622-6<\/li>\n
  4. Guo Q, Chen QJ, Zhang YJ, Zhou WX, Li XW, Li C, Zhang YW, Chen HY, Liu PX, Chu YC, Sun T, Jiang C*. Click-Nucleic-Acid-Containing Codelivery System Inducing Collapse of Cellular Homeostasis for Tumor Therapy through Bidirectional Regulation of Autophagy and Glycolysis. ACS Appl Mater Interfaces. 2020 Dec 30;12(52):57757-57767. doi: 10.1021\/acsami.0c18361.<\/li>\n
  5. Zhang YW, Jiang C*. Postoperative cancer treatments: In-situ delivery system designed on demand. Journal of Controlled Release<\/em>. 2020 Dec 22:S0168-3659(20)30762-8. doi: 10.1016\/j.jconrel.2020.12.038.<\/li>\n
  6. Zhou WX, Zhou Y, Chen XL, Ning TT, Chen HY, Guo Q, Zhang YW, Liu PX, Zhang YJ, Li C, Chu YC, Sun T, Jiang C*, Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment, Biomaterials<\/em>, Volume 268, 2021, 120546, ISSN 0142-9612, https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120546<\/a><\/li>\n
  7. Chen, QJ., He, YQ., Wang, Y., Li, C., Zhang, YJ., Guo, Q., Zhang, YW., Chu, YC., Liu, PX., Chen, HY., Zhou, Z., Zhou, WX., Zhao, ZH., Li, XM., Sun, T., Jiang, C.*, Penetrable Nanoplatform for \u201cCold\u201d Tumor Immune Microenvironment Reeducation. Advanced. Science.<\/em> 2020, 2000411. https:\/\/doi.org\/10.1002\/advs.202000411<\/a><\/li>\n
  8. Sun T, Ding XH, Wang XF, Zhang K, Zhang GP, Liang DH, Yu KJ, Chu YC, Chen QJ, Jiang C*. Carry-On Nitric-Oxide Luggage for Enhanced Chemotherapeutic Efficacy, Nano Letters<\/em>, 2020. DOI: 10.1021\/acs.nanolett.0c01532<\/li>\n
  9. Li C, Xie ZC, Chen QJ, Zhang YJ, Chu YC, Guo Q, Zhou WX, Zhang YW, Liu PX, Chen HY, Jiang C*, Sun KY*, Sun T*. Supramolecular Hunter Stationed on Red Blood Cells for Detoxification Based on Specific Molecular Recognition, ACS Nano<\/em>. 2020. DOI: 10.1021\/acsnano.0c01119<\/li>\n
  10. Sun T, Zhang GP, Guo ZY, Chen QJ, Zhang YJ, Chu YC, Guo Q, Li C, Zhou WX, Zhang YW, Liu PX, Chen HY, Yu HJ, Jiang LP, Jiang C*, Co-delivery of Cu(I) chelator and chemotherapeutics as a new strategy for tumor theranostic, Journal of Controlled Release<\/em>, Volume 321,2020, 483-496,<\/li>\n
  11. Guo Q, He X, Li C, He Y, Peng Y, Zhang Y, Lu Y, Chen X, Zhang Y, Chen Q, Sun T, Jiang C*. Dandelion\u2010Like Tailorable Nanoparticles for Tumor Microenvironment Modulation\uff0cAdvanced Science, 2019, 1901430.<\/li>\n
  12. Sun T, Zhang GP, Wang QB, Guo ZY, Chen QJ, Chen XL, Lu YF, Zhang Y, Zhang Y, Guo Q, Gao X, Cheng YZ, Chen Jiang*. Pre-blocked molecular shuttle as an in-situ real-time theranostics, Biomaterials,2019,204, 46-58,<\/li>\n
  13. Liu LS, Chen QJ, Ruan CH, Chen XL, He X, Zhang Y, Zhang YJ, Lu YF, Guo Q, Zhou WX, Li C, Sun T, Jiang C*. Nano-engineered lymphocytes for alleviating suppressive tumor immune microenvironment, Applied Materials Today, 2019, 273-279<\/li>\n
  14. Zhang Y, Zhang YJ, Guo Q, Guo ZY, Chen XL, Liu LS, Li C, Chen QJ, He X, Lu YF, Sun T, Huang YZ, and Jiang C*. Trained Macrophage Bioreactor for Penetrating Delivery of Fused Antitumor Protein. ACS Applied Materials & Interfaces, 2019, 11 (26), 23018-23025<\/li>\n
  15. Chen XL\uff0cZhou WX, Chen QJ, Sun T, Lu YF, Zhang YJ, Guo Q, Li C, Zhang Y, Liang C, Shi S, Yu XJ, Jiang C*. Codelivery Nanosystem Targeting the Deep Microenvironment of Pancreatic Cancer. Nanoletter, 2019, 9b00374<\/li>\n
  16. Lu YF, Li C, Chen QJ, Liu PX, Guo Q, Zhang Y, Chen XL, Zhang YJ, Zhou WX, Liang DH, Zhang YW, S Bun T, Lu WG*, Jiang C*. Microthrombus\u2010Targeting Micelles for Neurovascular Remodeling and Enhanced Microcirculatory Perfusion in Acute Ischemic Stroke. Advanced Materials, 2019, 1808361<\/li>\n
  17. Guo Q, Li C, Zhou WX, Chen XL, Zhang Y, Lu YF, Zhang YJ, Chen QJ, Liang DH, Sun T, Jiang C*. GLUT1-mediated effective anti-miRNA21 pompon for cancer therapy. Acta Pharmaceutica Sinica B 2019;9(4):832\u2013842<\/li>\n
  18. Chen QJ, Liu LS, Lu YF, Chen XL, Zhang YJ, Zhou WX, Guo Q, Li C, Zhang YW, Zhang Y, Liang DH, Sun T, Jiang C*. Tumor Microenvironment\u2010Triggered Aggregated Magnetic Nanoparticles for Reinforced Image\u2010Guided Immunogenic Chemotherapy. Advanced Science, 2019 Jan 29;6(6):1802134.<\/li>\n
  19. Zhang YJ, Zhu X, Chen XL, Chen QJ, Zhou WX, Guo Q, Lu YF, Li C, Zhang Y, Liang DH, Sun T, Wei XB, Jiang C*. Activated Platelets-Targeting Micelles with Controlled Drug Release for Effective Treatment of Primary and Metastatic Triple Negative Breast Cancer. Advanced Functional Materials, 2019, 29, 13, 1806620.<\/li>\n
  20. Lu YF, Guo ZY, Zhang YJ, Li C, Zhang Y, Guo Q, Chen QJ, Chen QJ, He X, LS, Ruan CH, Sun T, Ji B, Lu WG, Jiang C*. Microenvironment remodeling micelles for Alzheimer\u2019s disease therapy by early modulation of activated microglia. Advanced Science, 2018, 1801586<\/li>\n
  21. He X, Cai KM, Zhang Y, Lu YF, Guo Q, Zhang YJ, Liu LS, Ruan CH, Chen QJ, Chen XL, Li C, Sun T, Cheng JJ*, Jiang C*. Dimeric Prodrug Self-Delivery Nanoparticles with Enhanced Drug Loading and Bioreduction Responsiveness for Targeted Cancer Therapy. ACS Appl. Mater. Interfaces, 2018, 10 (46), 39455\u201339467.<\/li>\n
  22. He X, Chen XL, Liu LS, Zhang Y, Lu YF, Zhang YJ, Chen QJ, Ruan CH, Guo Q, Li C, Sun T, Jiang C*. Sequentiallygered nanoparticles with tumor penetration and intelligent drug release for pancreatic cancer therapy. Advanced Science, 2018, 1701070.<\/li>\n
  23. Zhang Y, Cai KM, Li C, Guo Q, Chen QJ, He X, Liu LS, Zhang YJ, Lu YF, Chen XL, Sun T, Huang YZ, Cheng JJ, Jiang C*. Macrophage membrane-coated nanoparticles for tumor-targeted chemotherapy. Nano Letters, 2018, 18, 1908-1915.<\/li>\n
  24. Zhang YJ, Guo ZY, Cao ZL, Zhou WX, Zhang Y, Chen QJ, Lu YF, Chen XL, Guo Q, Li C, Liang DH, Sun T, Jiang C*. Endogenous albumin-mediated delivery of redox responsive micelles for targeted cancer therapy. Biomaterials, 2018, 183, 243-257.<\/li>\n
  25. Chen XL, Wang QB, Liu LS, Sun T, Wenxi Zhou, Chen QJ, Lu YF, He X, Zhang Y, Zhang YJ, Ruan CH, Guo Q, Chao Li, Jiang C*. Double-sided effect of tumor microenvironment on platelets targeting nanoparticles. Biomaterials, 2018, 183, 258-267.<\/li>\n
  26. Sun T, Zhang GP, Wang QB, Chen QJ, Chen XL, Lu YF, Liu LS, Zhang Y, He X, Ruan CH, Zhang YJ, Guo Q, Jiang C*. A targeting theranostics nanomedicine as an alternative approach for hyperthermia perfusion. Biomaterials, 2018,183: 268-279.<\/li>\n
  27. He X, Zhang JX, Li C, Zhang Y, Lu YF, Zhang YJ, Liu LS, Ruan CH, Chen QJ, Chen XL, Guo Q, Sun T, Cheng JJ*, Jiang C*. Theranostics, 2018, 8 (18), 4884-4897.<\/li>\n
  28. Liu LS, Chen QJ, Ruan CH, Chen XL, Zhang Y, He X, Zhang YJ, Lu YF, Guo Q, Sun T, Wang H*, Jiang C*. Platinum-based nanovectors engineered with immune-modulating adjuvant for inhibiting tumor growth and promoting immunity. Theranostics, 2018, 8 (11), 2974-2987.<\/li>\n
  29. Ruan CH, Liu LS, Wang QB, Chen XL, Chen QJ, Lu YF, Zhang Y, He X, Zhang YJ, Guo Q, Sun T, Jiang C*. Reactive oxygen species-biodegradable gene carrier for the targeting therapy of breast cancer. ACS Applied Materials & Interfaces, 2018, 10 (12), 10398-10408.<\/li>\n
  30. Zhang YJ, Sun T, Jiang C*. Biomacromolecules as carriers in drug delivery and tissue engineering. Acta Pharmaceutica Sinica B, 2018, 8 (1), 34-50.<\/li>\n
  31. Ruan CH, Liu LS, Lu YF, Zhang Y, He X, Chen XL, Zhang YJ, Chen QJ, Guo Q, Sun T*, Jiang C*. Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma. Acta Pharmaceutica Sinica B, 2018, 8 (1), 85-96.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

    \u3010\u80cc\u666f\u4ecb\u7ecd\u3011 \u7ed3\u76f4\u80a0\u764c\u6781\u6613\u51fa\u73b0\u8179\u819c\u8f6c\u79fb\uff08CRC-PM\uff09\uff0c5\u5e74\u751f\u5b58\u7387\uff1c10%\u3002\u7531\u4e8e\u6563\u5728\u591a\u53d1\uff0c\u4e34\u5e8a\u4e0aCRC-PM\u7684\u793a\u8e2a\u4e0e\u6cbb\u7597\u5747\u6781\u5176\u56f0\u96be\u3002\u5176\u57fa\u7840\u65b9\u6848\u4e3a\u8179\u8154\u70ed\u704c\u6ce8\u5316\u7597\uff0c…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-225017","post","type-post","status-publish","format-standard","hentry","category-keji"],"_links":{"self":[{"href":"http:\/\/www.cailiaoniu.com\/index.php?rest_route=\/wp\/v2\/posts\/225017"}],"collection":[{"href":"http:\/\/www.cailiaoniu.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.cailiaoniu.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.cailiaoniu.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"http:\/\/www.cailiaoniu.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=225017"}],"version-history":[{"count":2,"href":"http:\/\/www.cailiaoniu.com\/index.php?rest_route=\/wp\/v2\/posts\/225017\/revisions"}],"predecessor-version":[{"id":225026,"href":"http:\/\/www.cailiaoniu.com\/index.php?rest_route=\/wp\/v2\/posts\/225017\/revisions\/225026"}],"wp:attachment":[{"href":"http:\/\/www.cailiaoniu.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=225017"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.cailiaoniu.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=225017"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.cailiaoniu.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=225017"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}